Review estimates 69% 3-dose vaccine efficacy against long COVID
https://www.cidrap.umn.edu/covid-19/review-estimates-69-3-dose-vaccine-efficacy-against-long-covid

A meta-analysis today in Antimicrobial Stewardship & Healthcare Epidemiology estimates a vaccine effectiveness (VE) of 69% for three doses of COVID-19 vaccine against long COVID, while two doses offer 37% efficacy.

Led by researchers at the University of Iowa, the meta-analysis involved 24 studies on COVID-19 VE against long COVID among recipients of at least two doses of a vaccine before or after infection from December 2019 to June 2023.



----
News about vaccine makers - all bad news, about how capitalism, the stock market, and public health are not compatible (it seems) without heavy government subsidies.

Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
https://www.cnbc.com/2023/10/13/pfizer-cuts-earnings-revenue-guidance-as-covid-sales-slump.html

Moderna Shares Slump Amid Concerns About COVID-19 Vaccine Demand
https://www.investopedia.com/moderna-shares-slump-amid-concerns-about-covid-19-vaccine-demand-8361950

Price of lifesaving Covid-19 antiviral Paxlovid expected to rise next year, raising concerns about access
https://www.cnn.com/2023/10/16/health/paxlovid-price-expected-to-rise/index.html